Search

Your search keyword '"Piggott, Thomas"' showing total 4 results
Start Over Author "Piggott, Thomas" Journal blood advances
4 results on '"Piggott, Thomas"'

1. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis

Author

Cuker, Adam, Tseng, Eric K., Nieuwlaat, Robby, Angchaisuksiri, Pantep, Blair, Clifton, Dane, Kathryn, Davila, Jennifer, DeSancho, Maria T., Diuguid, David, Griffin, Daniel O., Kahn, Susan R., Klok, Frederikus A., Lee, Alfred Ian, Neumann, Ignacio, Pai, Ashok, Righini, Marc, Sanfilippo, Kristen M., Siegal, Deborah, Skara, Mike, Terrell, Deirdra R., Touri, Kamshad, Akl, Elie A., Al Jabiri, Reyad Nayif, Al Jabiri, Yazan Nayif, Barbara, Angela M., Bognanni, Antonio, Bou Akl, Imad, Boulos, Mary, Brignardello-Petersen, Romina, Charide, Rana, Chan, Matthew, Colunga-Lozano, Luis E., Dearness, Karin, Darzi, Andrea J., Hussein, Heba, Karam, Samer G., Kolb, Philipp, Mansour, Razan, Morgano, Gian Paolo, Morsi, Rami Z., Muti-Schünemann, Giovanna, Nadim, Menatalla K., Noori, Atefeh, Philip, Binu A., Piggott, Thomas, Qiu, Yuan, Benitez, Yetiani Roldan, Schünemann, Finn, Stevens, Adrienne, Solo, Karla, Wiercioch, Wojtek, Mustafa, Reem A., and Schünemann, Holger J.

Published
2022
Full Text
View/download PDF

2. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients

Author

Cuker, Adam, Tseng, Eric K., Nieuwlaat, Robby, Angchaisuksiri, Pantep, Blair, Clifton, Dane, Kathryn, Davila, Jennifer, DeSancho, Maria T., Diuguid, David, Griffin, Daniel O., Kahn, Susan R., Klok, Frederikus A., Lee, Alfred Ian, Neumann, Ignacio, Pai, Ashok, Righini, Marc, Sanfilippo, Kristen M., Siegal, Deborah, Skara, Mike, Terrell, Deirdra R., Touri, Kamshad, Akl, Elie A., Bou Akl, Imad, Bognanni, Antonio, Boulos, Mary, Brignardello-Petersen, Romina, Charide, Rana, Chan, Matthew, Dearness, Karin, Darzi, Andrea J., Kolb, Philipp, Colunga-Lozano, Luis E., Mansour, Razan, Morgano, Gian Paolo, Morsi, Rami Z., Muti-Schünemann, Giovanna, Noori, Atefeh, Philip, Binu A., Piggott, Thomas, Qiu, Yuan, Roldan, Yetiani, Schünemann, Finn, Stevens, Adrienne, Solo, Karla, Wiercioch, Wojtek, Mustafa, Reem A., and Schünemann, Holger J.

Published
2021
Full Text
View/download PDF

3. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Author

Cuker, Adam, Tseng, Eric K., Nieuwlaat, Robby, Angchaisuksiri, Pantep, Blair, Clifton, Dane, Kathryn, Davila, Jennifer, DeSancho, Maria T., Diuguid, David, Griffin, Daniel O., Kahn, Susan R., Klok, Frederikus A., Lee, Alfred Ian, Neumann, Ignacio, Pai, Ashok, Pai, Menaka, Righini, Marc, Sanfilippo, Kristen M., Siegal, Deborah, Skara, Mike, Touri, Kamshad, A. Akl, Elie, Bou Akl, Imad, Boulos, Mary, Brignardello-Petersen, Romina, Charide, Rana, Chan, Matthew, Dearness, Karin, Darzi, Andrea J., Kolb, Philipp, Colunga-Lozano, Luis E., Mansour, Razan, Morgano, Gian Paolo, Morsi, Rami Z., Noori, Atefeh, Piggott, Thomas, Qiu, Yuan, Roldan, Yetiani, Schünemann, Finn, Stevens, Adrienne, Solo, Karla, Ventresca, Matthew, Wiercioch, Wojtek, Mustafa, Reem A., and Schünemann, Holger J.

Published
2021
Full Text
View/download PDF

4. ASH living guidelines on use of anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary

Author

Siegal, Deborah M., Tseng, Eric K., Schünemann, Holger J., Angchaisuksiri, Pantep, Cuker, Adam, Dane, Kathryn, DeSancho, Maria T., Diuguid, David, Griffin, Daniel O., Klok, Frederikus A., Lee, Alfred Ian, Neumann, Ignacio, Pai, Ashok, Righini, Marc, Sanfilippo, Kristen M., Terrell, Deirdra R., Akl, Elie A., Al Jabiri, Reyad, Al Jabiri, Yazan, Barbara, Angela M., Bognanni, Antonio, Akl, Imad Bou, Boulos, Mary, Brignardello-Petersen, Romina, Chan, Matthew, Charide, Rana, Colunga-Lozano, Luis E., Dearness, Karin, Darzi, Andrea J., Hussein, Heba, Karam, Samer G., Kolb, Philipp, Mansour, Razan, Morgano, Gian Paolo, Morsi, Rami Z., Muti- Schünemann, Giovanna, Nadim, Menatalla K., Noori, Atefeh, Philip, Binu A., Piggott, Thomas, Qiu, Yuan, Benitez, Yetiani Roldan, Schünemann, Finn, Stevens, Adrienne, Solo, Karla, Wiercioch, Wojtek, Mustafa, Reem A., and Nieuwlaat, Robby

Abstract

COVID-19-related critical and acute illness are associated with an increased risk of venous thromboembolism (VTE). These evidence-based recommendations of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other healthcare professionals in decisions about the use of anticoagulation for thromboprophylaxis in patients with COVID-19-related critical illness, acute illness, and those being discharged from the hospital, who do not have suspected or confirmed VTE. ASH formed a multidisciplinary panel, including three patient representatives, and applied a conflicts of interest management policy to minimize potential bias. The Michael G. DeGroote Cochrane Canada and MacGRADE Centres at McMaster University supported the guideline development process, including performing systematic evidence reviews (up to June 2023). The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assess certainty of the evidence and make recommendations, which were subject to public comment. This is an executive summary of three updated recommendations that have been published which concludes the living phase of the guidelines. For critically ill patients with COVID-19, the panel issued conditional recommendations in favor of (a) prophylactic-intensity over therapeutic-intensity anticoagulation and (b) prophylactic-intensity over intermediate-intensity anticoagulation. For acutely ill patients with COVID-19, conditional recommendations were made in favor of (a) prophylactic-intensity over intermediate-intensity anticoagulation and (b) therapeutic-intensity over prophylactic-intensity anticoagulation. The panel also issued a conditional recommendation against the use of post-discharge extended pharmacologic thromboprophylaxis. These three conditional recommendations were made based on low or very low certainty in the evidence, underscoring the need for additional, high-quality randomized controlled trials in patients with COVID-19-related illness.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results